Cargando…

Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2

Detalles Bibliográficos
Autores principales: Valaiyapathi, R., Barton, L., Carvalho, L., David, A., Walji, S., Jones, B., Cegla, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582078/
http://dx.doi.org/10.1016/j.athplu.2022.07.007
_version_ 1784812760162369536
author Valaiyapathi, R.
Barton, L.
Carvalho, L.
David, A.
Walji, S.
Jones, B.
Cegla, J.
author_facet Valaiyapathi, R.
Barton, L.
Carvalho, L.
David, A.
Walji, S.
Jones, B.
Cegla, J.
author_sort Valaiyapathi, R.
collection PubMed
description
format Online
Article
Text
id pubmed-9582078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-95820782022-10-20 Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2 Valaiyapathi, R. Barton, L. Carvalho, L. David, A. Walji, S. Jones, B. Cegla, J. Atheroscler Plus Article Published by Elsevier B.V. 2022-10 2022-10-20 /pmc/articles/PMC9582078/ http://dx.doi.org/10.1016/j.athplu.2022.07.007 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Valaiyapathi, R.
Barton, L.
Carvalho, L.
David, A.
Walji, S.
Jones, B.
Cegla, J.
Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
title Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
title_full Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
title_fullStr Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
title_full_unstemmed Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
title_short Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody levels in patients with familial hypercholesterolaemia after vaccination with BNT162b2
title_sort lipoprotein apheresis reduces sars-cov-2 s protein antibody levels in patients with familial hypercholesterolaemia after vaccination with bnt162b2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582078/
http://dx.doi.org/10.1016/j.athplu.2022.07.007
work_keys_str_mv AT valaiyapathir lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2
AT bartonl lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2
AT carvalhol lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2
AT davida lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2
AT waljis lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2
AT jonesb lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2
AT ceglaj lipoproteinapheresisreducessarscov2sproteinantibodylevelsinpatientswithfamilialhypercholesterolaemiaaftervaccinationwithbnt162b2